Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.230
+0.030 (2.50%)
At close: Aug 21, 2026, 4:00 PM EDT
1.200
-0.030 (-2.44%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $46.47 million as of August 21, 2026. Its market cap has decreased by -33.08% in one year.
Market Cap
46.47M
Enterprise Value
-36.48M
1-Year Change
-33.08%
Ranking
Category
Stock Price
$1.23
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $46.47M, a decrease of -91.75%. That is a compound annual growth rate of -62.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 46.47M | -23.61% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 48.44M |
| Context Therapeutics | 47.75M |
| Veraxa Biotech AG | 47.66M |
| Mereo BioPharma Group | 46.84M |
| Nutriband | 46.38M |
| Edesa Biotech | 45.85M |
| Filana Therapeutics | 45.53M |
| Seres Therapeutics | 45.43M |